Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.16%) 5 336.00 points
Dow Jones Futures
(0.06%) 40 161 points
Nasdaq Futures
(0.25%) 18 683 points
Oil
(-0.40%) $79.74
Gas
(1.45%) $2.66
Gold
(0.74%) $2 435.20
Silver
(1.44%) $31.71
Platinum
(-0.58%) $1 083.70
USD/EUR
(0.06%) $0.920
USD/NOK
(0.02%) $10.68
USD/GBP
(0.05%) $0.787
USD/RUB
(-0.48%) $90.54

Realtime updates for Dynavax Technologies [0IDA.L]

Exchange: London Stock Exchange Sector: Healthcare Industry: Medical - Pharmaceuticals
Last Updated20 May 2024 @ 07:08
25% discount on Stockinvest.us - Use code: Podcast

0.82% $ 11.20

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 07:08):

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe...

Stats
Today's Volume 38.00
Average Volume 1 118.00
Market Cap 1.47B
EPS $0 ( 2024-05-08 )
Next earnings date ( $0 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 14.87
ATR14 $0 (0.00%)

Dynavax Technologies Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dynavax Technologies Financials

Annual 2023
Revenue: $232.28M
Gross Profit: $182.12M (78.40 %)
EPS: $-0.0496
FY 2023
Revenue: $232.28M
Gross Profit: $182.12M (78.40 %)
EPS: $-0.0496
FY 2022
Revenue: $722.68M
Gross Profit: $460.53M (63.73 %)
EPS: $2.32

Financial Reports:

No articles found.

Dynavax Technologies Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Dynavax Technologies

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators